一脉阳光(02522)发布公告，该公司于2025年11月24日斥资51.72万港元回购3.45万股股份，每股回购价 格为14.86-15.06港元。 ...

格隆汇11月24日丨一脉阳光(02522.HK)公告，11月24日耗资51.7万港元回购3.5万股。 ...

呈交日期： 2025年11月24日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | H | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 02522 | 說明 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | | 庫存股份變動 | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | | 佔有關事件前的現有已發 行股份（不包括庫存股 份）數目百分比 (註3) | 庫存股份數目 | 每股發行/出售價 (註4) | 已發行股份總數 | | 於下列日期開始時的結存(註1) | ...

Group 1 - The core point of the article is that southbound funds have increased their holdings in Yipai Sunshine (02522.HK), with a total net increase of 443.35 million shares over the last five trading days [1][2] - As of November 21, 2025, southbound funds hold 130 million shares of Yipai Sunshine, accounting for 44.32% of the company's total issued ordinary shares [1][2] - The increase in holdings has been observed on three out of the last five trading days, indicating a positive trend in investor sentiment towards the company [1][2] Group 2 - Yipai Sunshine Group Co., Ltd. is primarily engaged in specialized medical imaging services in China, providing imaging services and solutions [2] - The company operates three segments: imaging center services, imaging solutions, and Yipai cloud services, which support the development of imaging center services and data-driven operations [2]

Core Viewpoint - Southbound funds have increased their holdings in Yipai Sunshine (02522.HK) by 2,002,500 shares on November 20, 2025, indicating a growing interest from investors in the company [1]. Summary by Sections Southbound Fund Holdings - In the last five trading days, southbound funds have increased their holdings on three occasions, with a total net increase of 2,597,000 shares [1]. - Over the past 20 trading days, there have been nine days of net increases, totaling 791,500 shares [1]. - As of now, southbound funds hold 128 million shares of Yipai Sunshine, accounting for 43.63% of the company's total issued ordinary shares [1]. Trading Data - On November 20, 2025, the total number of shares held was 128 million, with a change of 2,002,500 shares, reflecting a 1.59% increase [2]. - On November 19, 2025, the total was 126 million shares, with an increase of 886,000 shares, or 0.71% [2]. - On November 18, 2025, the total was 125 million shares, with a decrease of 40,000 shares, or -0.03% [2]. - On November 17, 2025, the total remained at 125 million shares, with a decrease of 436,000 shares, or -0.35% [2]. - On November 14, 2025, the total was 126 million shares, with an increase of 184,500 shares, or 0.15% [2]. Company Overview - Jiangxi Yipai Sunshine Group Co., Ltd. primarily engages in specialized medical imaging services in China [2]. - The company offers imaging services and solutions, operating through three divisions: imaging center services, imaging solutions, and Yipai cloud services [2]. - Imaging center services provide diagnostic imaging examinations to patients and healthcare consumers through flagship imaging centers [2]. - Imaging solutions assist hospitals and medical institutions in selecting and procuring suitable imaging equipment, along with providing modular solutions [2]. - Yipai cloud services support the development of imaging center services, information management, and data-driven operations [2].

Core Insights - The company is a leading third-party medical imaging service platform in China, entering a performance recovery phase with a revenue of 467 million yuan in the first half of 2025, representing a year-on-year growth of 12.9% [1] - The revenue from imaging solutions reached 161 million yuan, showing a significant increase of 88.9%, and its revenue contribution rose to 34.5% [1] - The net profit attributable to the parent company was 16 million yuan, reflecting a substantial year-on-year growth of 328.1% due to active cost control and efficiency improvements [1] Business Model and Infrastructure - The company has established a nationwide imaging center network with 115 operational centers across 17 provinces, creating multiple barriers such as equipment, licenses, and brand resources [1] - The imaging centers serve as both a revenue stabilizer and a primary production site for high-quality structured imaging data, facilitating data assetization and AI training [1] Data Assetization and AI Development - The company has accumulated a high-quality medical imaging database covering over 200 disease types and more than 10 million cases, with a daily addition of 20,000 to 30,000 structured data entries [1] - It has successfully explored the full process of "data resources → data assets → data trading," with multiple imaging data products listed and traded on data exchanges [1] - The company has launched a full-modal, full-process medical imaging foundation model (MIIA) and AI-assisted diagnostic products (AIR), achieving leading results in image understanding and report generation [1] Financial Projections - Revenue projections for 2025-2027 are 1.05 billion, 1.39 billion, and 1.68 billion yuan, with year-on-year growth rates of 38.1%, 32.2%, and 21.2% respectively [2] - Net profit estimates for the same period are 25 million, 60 million, and 105 million yuan, with significant growth rates of 137.7% and 76.5% in 2026 and 2027 [2] - The company is expected to achieve an EBITDA of 236 million, 282 million, and 341 million yuan, with year-on-year growth rates of 43.0%, 19.5%, and 20.9% [2] Valuation and Investment Rating - Given the company's leadership position in the third-party medical imaging industry and its future potential as a medical data asset operator, a target market capitalization of 11.11 billion yuan is projected, corresponding to a target price of 30.4 HKD [2]

Group 1 - The company Yipai Yangguang (02522) announced a share buyback on November 19, 2025, costing approximately HKD 529,300 [1] - A total of 31,000 shares were repurchased during this transaction [1]

Group 1 - The company, Yipai Yangguang (02522), announced a share buyback on November 19, 2025, costing approximately HKD 529,300 [1] - A total of 31,000 shares were repurchased during this transaction [1]

Core Viewpoint - The company, 一脉阳光 (02522.HK), announced a share buyback on November 19, spending HKD 529,000 to repurchase 31,000 shares [1] Group 1 - The total expenditure for the share buyback was HKD 529,000 [1] - The number of shares repurchased was 31,000 [1]

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 H | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 02522 | 說明 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | 庫存股份變動 | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | 佔有關事件前的現有已發 行股份（不包括庫存股 份）數目百分比 (註3) | 庫存股份數目 | 每股發行/出售價 ( ...